Literature DB >> 12941952

Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation.

Elizabeth M Wilson1, Marlene M Hsieh, Peter Rotwein.   

Abstract

Skeletal muscle differentiation, maturation, and regeneration are regulated by interactions between intrinsic genetic programs controlled by myogenic transcription factors, including members of the MyoD and MEF2 families, and environmental cues mediated by hormones and growth factors. Insulin-like growth factors (IGFs) also play key roles in muscle development, and in the maintenance and repair of mature muscle, but their mechanisms of interaction with other muscle regulatory networks remain undefined. To evaluate the potential interplay between MyoD and IGF signaling pathways, we have studied muscle differentiation in C3H 10T1/2 fibroblasts acutely converted to myoblasts by quantitative infection with a recombinant adenovirus encoding mouse MyoD. In these cells, IGF-II gene and protein expression are induced as early events in differentiation, and the IGF-I receptor and downstream signaling molecules, including Akt, are rapidly activated. Interference with IGF-II production by a tetracycline-inhibited adenovirus expressing an IGF-II cDNA in the antisense orientation reversibly inhibited both production of muscle-specific structural proteins and myocyte fusion to form multinucleated myotubes. Similar results were achieved with a tetracycline-inhibited adenovirus expressing dominant-negative Akt. Our observations identify a robust autocrine amplification network in which MyoD enhances the later steps in muscle differentiation by induction of a locally acting growth factor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941952     DOI: 10.1074/jbc.C300299200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  43 in total

1.  Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression.

Authors:  Mahta Nili; Ujwal Shinde; Peter Rotwein
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  O(2) regulates skeletal muscle progenitor differentiation through phosphatidylinositol 3-kinase/AKT signaling.

Authors:  Amar J Majmundar; Nicolas Skuli; Rickson C Mesquita; Meeri N Kim; Arjun G Yodh; Michelle Nguyen-McCarty; M Celeste Simon
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

3.  Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

4.  A non-isotopic in vitro assay for histone acetylation.

Authors:  David Kuninger; James Lundblad; Anthony Semirale; Peter Rotwein
Journal:  J Biotechnol       Date:  2007-07-12       Impact factor: 3.307

5.  Akt promotes BMP2-mediated osteoblast differentiation and bone development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  J Cell Sci       Date:  2009-02-10       Impact factor: 5.285

6.  Role of phosphatidylinositol 3,4,5-trisphosphate (PIP3) 5-phosphatase skeletal muscle- and kidney-enriched inositol polyphosphate phosphatase (SKIP) in myoblast differentiation.

Authors:  Takeshi Ijuin; Tadaomi Takenawa
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

7.  Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation.

Authors:  Peter Rotwein; Elizabeth M Wilson
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

8.  Transcriptional regulation of the IGF signaling pathway by amino acids and insulin-like growth factors during myogenesis in Atlantic salmon.

Authors:  Neil I Bower; Ian A Johnston
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  Defining Akt actions in muscle differentiation.

Authors:  Samantha Gardner; Magdalena Anguiano; Peter Rotwein
Journal:  Am J Physiol Cell Physiol       Date:  2012-10-17       Impact factor: 4.249

10.  Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2008-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.